Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study: Am J Cancer Res. 2023; 13(10): 4547-4559
American Journal of Cancer Research · 2026 · 16 (2) · 769-770
DOI: 10.62347/hwee4799 ↗Kurz gefasst
Korrektur in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Wei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of PET-CT/MRI, Harbin Medical University, Harbin Medical University Cancer Hospital Harbin 150081, Heilongjiang, China.
Zitieren
APA
Li, W., Jiang, Z., Cui, N., Li, J., Cheng, L., Liu, W., Li, J., & Wang, K. (2026). Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study: Am J Cancer Res. 2023; 13(10): 4547-4559. American Journal of Cancer Research, 16(2), 769-770. https://doi.org/10.62347/hwee4799
Vancouver
Li W, Jiang Z, Cui N, Li J, Cheng L, Liu W, et al. Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study: Am J Cancer Res. 2023; 13(10): 4547-4559. American Journal of Cancer Research. 2026;16(2):769-770. doi:10.62347/hwee4799
BibTeX
@article{Li2026,
author = {Li, Wei and Jiang, Zhiyun and Cui, Nan and Li, Jiatong and Cheng, Liang and Liu, Wei and Li, Jing and Wang, Kezheng},
title = {Superiority of FAPI-PET/CT for examining multiple malignant tumors: a retrospective study: Am J Cancer Res. 2023; 13(10): 4547-4559},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {2},
pages = {769--770},
doi = {10.62347/hwee4799}
}
EUVIMED